Advertisement

Meat in point

Reading Time:3 minutes
Why you can trust SCMP
0

Imagine eating the same steak year in year out. We're not talking about the same breed of cow, or cows from one unbroken lineage (something of an obsession for certain Japanese when it comes to Kobe beef, which is sometimes served with the cow's birth certificate on display). The impending adoption of cloning in mainstream agribusiness opens up the possibility that all tenderloin medallions in your gastronomic future will be genetically identical.

In January, researchers at Japan's Kinki University announced they had resurrected the ancestral bull of a high-end Hida-gyu brand of beef. Yasufuku, the bull, died 16 years ago and his testicles were kept frozen until 2007, when the researchers started to clone four calves from his genetic material, though one died before reaching adulthood. Researchers said they planned to study the gene and protein structures that make tastier beef, rather than apply such elements to food production, according to Agence France-Presse. A couple of weeks later, Reuters reported that Japan's health ministry had announced that cloned animals are safe to eat. The Food Safety Commission is expected to make a further ruling in the coming months.

Cloning of mammals has come a long way since the 1996 birth of Dolly the sheep in Scotland but the first push to use this technology in food production came from the United States. In 2003, the Federal Department of Agriculture assessed that meat and dairy products from cloned animals were safe for human consumption. The news was met with an overwhelmingly negative response from the public and, in the same year, there was a voluntary industry ban on using cloned animals in food production. However, this informal ban did not stop the development of laboratories providing commercial cloning services on a small scale.

Companies such as ViaGen and Trans Ova Genetics typically charge about US$15,000 to clone a bull and US$3,000 for a pig and reportedly churn out 150 clones annually.

With the release of its final risk assessment on the issue in January last year, the FDA cleared the way for clones to enter the food supply, albeit pending a transition period. However, products from the offspring of clones were granted immediate release into the market.

It is commonly known that clones are more likely to die in utero or shortly after birth and to have birth defects. But according to a 2006 study commissioned by the FDA, clones that survive into adolescence are as healthy as animals born naturally.

Advertisement
Select Voice
Choose your listening speed
Get through articles 2-3x faster
1.1x
220 WPM
Slow
Normal
Fast
1.1x